关于“神州高铁”的报告
-
-
-
-
-
艾媒咨询|2021年9-10月中国企业服务行业投融资数据分析简报
数字经济蓬勃发展，数字化转型逐步成为企业发展的必然要求。在此情境下，数字化产品或服务也越来越受到数字化转型企业的青睐。近年来，在新兴技术的加持下，企业服务产业创新不断涌现，并发展成为最活跃的行业之一，相关细分赛道也维持着较高的增长，收获了资本市场的大量关注。艾媒咨询通过艾媒数据中心(data.iimedia.cn)查询并发布《2021年9-10月中国企业服务行业投融资数据分析简报》，助力投资人与创业者用户即时了解市场趋势，获取关键投资决策所需的数据，把握投资逻辑和最新产业机会。
With the vigorous development of digital economy, digital transformation has gradually become an inevitable requirement for enterprise development. In this context, digital products or services are increasingly favored by digital transformation enterprises. In recent years, with the support of emerging technologies, the innovation of enterprise service industry has continuously emerged and developed into one of the most active industries. The relevant segments have also maintained high growth and gained a lot of attention from the capital market.Iimedia inquires and publishes the investment and financing data analysis briefing of China's enterprise service industry from September to October 2021 through iimedia data center (data. Iimedia. CN), so as to help investors and entrepreneurs understand the market trend in real time, obtain the data required for key investment decisions, and grasp the investment logic and the latest industrial opportunities. -
艾媒咨询|2021年9月中国医疗健康行业投融资数据分析报告
人口老龄化，人均GDP、人均收入的提升，同时也带来了人们健康需求的增长。近年来，医疗健康产业创新不断涌现，并发展成为最活跃的行业之一，相关细分赛道也维持着较高的增长，收获了资本市场的大量关注。
艾媒咨询通过艾媒数据中心(data.iimedia.cn)查询并发布《2021年9月中国医疗健康行业投融资数据分析简报》，助力投资人与创业者用户即时了解市场趋势，获取关键投资决策所需的数据，把握投资逻辑和最新产业机会。(《艾媒咨询|2021年9月中国医疗健康行业投融资数据分析报告》完整高清PDF版共21页，可点击文章底部报告下载按钮进行报告下载)
The aging of population and the increase of per capita GDP and per capita income have also brought about the growth of people's health demand. In recent years, the innovation of medical and health industry has been emerging and developed into one of the most active industries. The relevant segments have also maintained high growth and gained a lot of attention from the capital market.
Iimedia inquires and publishes the analysis briefing on investment and financing data of “China's medical and health industry in September 2021 through iimedia data center (data. Iimedia. cn), so as to help investors and entrepreneurs understand the market trend in real time, obtain the data required for key investment decisions, and grasp the investment logic and the latest industrial opportunities.(“iiMedia Report |Analysis report on investment and financing data of China's medical and health industry in September 2021”full version has 21 pages in total, please click the Browse HD Report button on the right side of the article to browse the report) -
艾媒咨询|2021年上半年中国共享出行发展专题研究报告
本报告研究涉及企业/品牌/案例：青桔单车，美团单车，滴滴出行，曹操出行，哈啰单车，神州租车，EVCARD
在共享出行领域中，共享单车、电单车进入稳步发展阶段，特别随着碳中和、健康出行等倡议以及用户逐渐适应市场，共享单车和电单车的用户规模将有一个大幅跃升空间。iiMedia Research(艾媒咨询)数据显示，2019年中国共享电单车数量已达100万辆。预计2025年共享电单车投放车辆将达到800万辆。而网约车领域则开始更关注用户体验和司机权益，iiMedia Research（艾媒咨询）数据显示，大部分用户认为网约车的安全措施如“行程分享”“行程录音”“紧急联系人”“车辆与司机的一致性审查”很有必要，能一定程度上减少网约车违法犯罪行为的发生。
In the field of shared travel, shared bicycles and motorcycles have entered a stage of steady development. Especially with initiatives such as carbon neutrality and healthy travel, and users gradually adapt to the market, the user scale of shared bicycles and motorcycles will have a significant leap. According to data from iiMedia Research, the number of shared motorcycles in China in 2019 has reached 1 million. It is estimated that 8 million shared motorcycles will be launched in 2025. The field of online car-hailing has begun to pay more attention to user experience and driver rights. According to data from iiMedia Research, most users believe that the safety measures for online car-hailing are "trip sharing", "trip recording", and "emergency contacts". It is necessary to check the consistency between the vehicle and the driver, which can reduce the occurrence of illegal and criminal behaviors of online car-hailing to a certain extent. -
-
艾媒咨询|2020年中国细胞生物产业和商业应用分析报告
本报告研究涉及企业/品牌/案例：华夏源、复星医药。
中国细胞生物产业类型呈现多样化趋势，细胞生物临床研究不断深化，伴随生态合作的拓展将进一步加速细胞生物产业生态圈的形成，生态圈的完善将在很大限度上推动产业快速发展。数据显示，中国细胞治疗企业融资金额不断增加，从2014年的0.2亿元增长至2019年的28.9亿元。其中，2018年中国细胞治疗企业融资额同比增长706.8%，呈现迅猛发展态势。未来中国细胞生物产业的发展将充满机遇，同时也有挑战并存。后续产业的发展，将在5G、人工智能等新技术应用下加速升级。面临多端变化的市场格局，企业也应积极开展生态合作以及更为密切关注市场需求动向，将疗法和新一代医疗创新技术深度融合，实现市场产品多元化与差异化，并推出独特性的精准治疗，从而最大限度地释放产业价值。
The types of cell biological industry in China show a trend of diversification, and the deepening of cell biological clinical research will further accelerate the formation of the cell biological industry ecosystem with the expansion of ecological cooperation, and the improvement of the ecosystem will promote the rapid development of the industry to a large extent. Data show that the financing amount of Chinese cell therapy enterprises keeps increasing, from 20 million yuan in 2014 to 2.89 billion yuan in 2019. Among them, in 2018, the financing amount of Chinese cell therapy enterprises increased by 706.8% year on year, showing a rapid development trend. In the future, the development of China's cell biology industry will be full of opportunities and challenges. The development of subsequent industries will be accelerated with the application of new technologies such as 5G and ARTIFICIAL intelligence. In the face of the changing market pattern, enterprises should also actively carry out ecological cooperation and pay close attention to the trend of market demand, deeply integrate therapy and new-generation medical innovation technology, realize the diversification and differentiation of market products, and launch unique precision therapy, so as to maximize the release of industrial value.
- 1
- 2
- 3
- 4
- 5
- 6
- 8
